Although NDUFA6, YWHAZ, DLAT, BDNF, ECI2, ACO1, and ALDH7A1 have not been extensively studied in IDD, further validation may reveal their potential as novel therapeutic targets. The gene discussed is ACO1; the disease is intervertebral disk degenerative disorder.